Physician profile
Anthony Fiorilli
NPI 1831167568
$1,006.84
in general payments reported to CMS, 2019-2025
11 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.22 · 2020: $105 · 2021: $182 · 2022: $74.99 · 2023: $167 · 2024: $318 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $717.12 | 2019-2025 | Affinity, Puraply, Puraply Wound Matrix |
| Urgo Medical North America, LLC | $62.46 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Misonix INC | $50.47 | 2020-2021 | |
| Kerecis Limited | $28.99 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbvie INC. | $28.50 | 2021 | |
| Bioventus LLC | $27.73 | 2023 | |
| Acera Surgical, INC. | $27.22 | 2025 | Restrata Wound Matrix |
| Molnlycke Health Care US, LLC | $20.84 | 2024 | Exufiber Ag+, Mepilex Border Post-Op Ag, Mepilex Transfer |
| Integra Lifesciences Corporation | $16.32 | 2020 | |
| Smith+Nephew, INC. | $14.00 | 2021 | |
| Convatec INC. | $13.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Fiorilli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.